Gerard Ber
CIK 1762144 · last filed 2026-06-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.83M
Companies
3
Total Filings
24
Lifetime Open-Market Net
-$1.58M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LNTH | Director | 27,118 | $104.52 | $2.83M | -$1.57M | 15 | 2026-06-03 |
| Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Director | 1,608 | $8.61 | $13.8K | -$8.7K | 6 | 2024-06-11 |
| PROGENICS PHARMACEUTICALS INC (PGNX) Delisted | Director | — | — | — | $0 | 2 | 2019-12-17 |
Recent Filings · Page 3 of 3
24 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-06-23 | — | Disp (D) | −50,000 | $0 | |
| 2019-12-17 | PROGENICS PHARMACEUTICALS INC (PGNX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-12-17 | PROGENICS PHARMACEUTICALS INC (PGNX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-06-14 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 21–24 of 24
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.